Skip to main content

Table 4 Organisms isolated from febrile neutropenic patients

From: Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country

Organism

n (%)

Gram-positive bacteria

34 (53.96)

 Enterococcus fecalis

9 (14.3)

 Clostridioides difficile

6 (9.5)

 Lactobacilli

3 (4.8)

 Staphylococcus epidermidis

2 (3.2)

 Streptococcus oralis

2 (3.2)

 Corynebacteria

2 (3.2)

 MRSA

1 (1.6)

 MSSA

1 (1.6)

 Staphylococcus haemolyticus

1 (1.6)

 Staphylococcus cohnii

1 (1.6)

 Staphylococcus capitis

1 (1.6)

 Streptococcus agalactiae

1 (1.6)

 Streptococcus gallolyticus

1 (1.6)

 Streptococcus parasangunis

1 (1.6)

 Micrococcus luteus

1 (1.6)

 VRE

1 (1.6)

Gram-negative bacteria

22 (34.92)

 Klebsiella pneumoniae

5 (7.9)

 Pseudomonas aeruginosa

4 (6.3)

 ESBL-E. coli

3 (4.8)

 Acinetobacter baumannii

3 (4.8)

 Non-ESBL E. coli

2 (3.2)

 Neisseria sicca

2 (3.2)

 Sphingomonas paucimobilis

1 (1.6)

 Escherichia fergusonii

1 (1.6)

 Pseudomonas stutzeri

1 (1.6)

Fungi

2 (3.2)

 Candida tropicalis

1 (1.6)

 Candida glabrata

1 (1.6)

Protozoa

1 (1.6)

 Entamoeba histolytica

1 (1.6)

Viruses

4 (6.3)

 Coronavirus

4 (6.3)

Total

63 (100)

  1. MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus; ESBL, extended-spectrum beta-lactamase